HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program

Supplemental Digital Content is Available in the Text. Introduction: Pre-exposure prophylaxis (PrEP) is proven to be a highly effective HIV prevention method for key populations. However, its scale-up in resource-limited settings remains suboptimal. This paper seeks to describe PrEP initiation and continuation among key populations in Cameroon. Methodology: From June 2019 through October 2020, we collected routine program data on PrEP uptake and continuation among female sex workers (FSWs) and men who have sex with men (MSM) in the Continuum of prevention, care and treatment of HIV/AIDS with Most-at-risk Populations (CHAMP) program in Cameroon. PrEP was offered to clients who tested negative for HIV and were assessed to potentially benefit from PrEP. Using survival analysis, we identified factors associated with PrEP discontinuation over time with significance set at 5%. Results: Overall, 27,750 clients were sensitized for PrEP of whom 3,138 persons were eligible to start PrEP and 1,409 (45%; FSW: 691 and MSM: 718) initiated PrEP. The PrEP continuation rate was 37% at 3 months, 28% at 6 months and 19% at 12 months. PrEP discontinuation was significantly higher among FSW than MSM [adjusted hazard ratio (aHR) 1.5 (95% CI: 1.2 to 1.9)] in Yaounde [aHR 1.5 (95% CI: 1.2 to 1.9)] and Bafoussam/Bertoua [aHR 3.1 (2.2–4.5)] relative to Douala. Discontinuation was lower among those with moderate [aHR 0.3 (0.3–0.4)] or good adherence [aHR 0.4 (0.3–0.6)] compared with poor adherence (all P < 0.001). Conclusion: Differentiated approaches to deliver PrEP, create demand, and provide more intensive support for adherence and continuation may support scale-up of PrEP in Cameroon for equitable and prolonged impact on HIV prevention.

[1]  T. Holtz,et al.  Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. , 2021, The New England journal of medicine.

[2]  David Bruce Lewis,et al.  Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study. , 2021, The lancet. HIV.

[3]  K. Mayer,et al.  Key populations are the future of the African HIV/AIDS pandemic , 2021, Journal of the International AIDS Society.

[4]  B. Spire,et al.  HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. , 2021, The lancet. HIV.

[5]  J. Seeley,et al.  Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa , 2021, Archives of Sexual Behavior.

[6]  P. Phanuphak,et al.  Demedicalisation of HIV interventions to end HIV in the Asia-Pacific. , 2021, Sexual health.

[7]  Joshua R. Nugent,et al.  HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. , 2021, PLoS medicine.

[8]  V. Veloso,et al.  High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil , 2020, The Brazilian Journal of Infectious Diseases.

[9]  A. Phillips,et al.  Understanding early uptake of PrEP by female sex workers in Zimbabwe , 2020, AIDS care.

[10]  S. Novío,et al.  Knowledge, Attitudes, and Intentions towards HIV Pre-Exposure Prophylaxis among Nursing Students in Spain , 2020, International journal of environmental research and public health.

[11]  G. Gottlieb,et al.  Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal , 2020, International journal of STD & AIDS.

[12]  B. Friedland,et al.  Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake , 2020, BMJ Sexual & Reproductive Health.

[13]  J. Baeten,et al.  Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa , 2020, Gates open research.

[14]  P. Ongwen,et al.  Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study , 2020, Journal of the International AIDS Society.

[15]  P. Phanuphak,et al.  Evaluation of a pre‐exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens , 2020, Journal of the International AIDS Society.

[16]  Patrick D. Herron.  Current Perspectives on the Impact of Pre-Exposure Prophylaxis Stigma Regarding Men Who Have Sex with Men in the United States , 2020, HIV/AIDS.

[17]  S. Mullick,et al.  Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa , 2020, PloS one.

[18]  M. Hellard,et al.  HIV pre‐exposure prophylaxis for female sex workers: ensuring women’s family planning needs are not left behind , 2020, Journal of the International AIDS Society.

[19]  G. Emmanuel,et al.  Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria , 2020, BMC Public Health.

[20]  J. Baeten,et al.  Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa. , 2020, Gates open research.

[21]  J. Glick,et al.  The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review , 2019, AIDS and Behavior.

[22]  J. Snowden,et al.  Words Matter: Putting an End to “Unsafe” and “Risky” Sex , 2019, Sexually transmitted diseases.

[23]  U. Tamoufé,et al.  Characterising unmet HIV prevention and treatment needs among young female sex workers and young men who have sex with men in Cameroon: a cross-sectional analysis. , 2019, The Lancet. Child & adolescent health.

[24]  M. Petersen,et al.  Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda , 2019, Journal of the International AIDS Society.

[25]  Gabrielle E. O'Malley,et al.  Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART? , 2019, Current HIV/AIDS Reports.

[26]  M. Alary,et al.  Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up. , 2019, Gates open research.

[27]  Ricki S. Loar,et al.  Demand creation for primary biomedical prevention: identifying lessons across interventions to inform daily oral preexposure prophylaxis programs , 2019, Current opinion in HIV and AIDS.

[28]  Michael R. Kramer,et al.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. , 2018, Annals of epidemiology.

[29]  Elizabeth Irungu,et al.  Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study. , 2018, Sexual health.

[30]  S. Golub,et al.  PrEP Stigma: Implicit and Explicit Drivers of Disparity , 2018, Current HIV/AIDS Reports.

[31]  J. Parsons,et al.  Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men , 2018, AIDS and Behavior.

[32]  Charlene A Flash,et al.  Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States , 2017, Journal of acquired immune deficiency syndromes.

[33]  D. Vlahov,et al.  HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic , 2018, AIDS and Behavior.

[34]  P. Phanuphak,et al.  Importance of Risk Perception: Predictors of PrEP Acceptance Among Thai MSM and TG Women at a Community-Based Health Service , 2017, Journal of Acquired Immune Deficiency Syndromes.

[35]  M. Clark,et al.  Potential Healthcare Insurance and Provider Barriers to Pre‐Exposure Prophylaxis Utilization Among Young Men Who Have Sex with Men , 2017, AIDS patient care and STDs.

[36]  F. Kapadia,et al.  Preexposure Prophylaxis: Adapting HIV Prevention Models to Achieve Worldwide Access. , 2017, American Journal of Public Health.

[37]  P. Holland,et al.  Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis , 2017, Journal of the International AIDS Society.

[38]  J. Ananworanich,et al.  A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up , 2017, Journal of the International AIDS Society.

[39]  T. Hallett,et al.  PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa , 2016, Journal of the International AIDS Society.

[40]  S. Delany-Moretlwe,et al.  PrEP implementation research in Africa: what is new? , 2016, Journal of the International AIDS Society.

[41]  Ashley J. Mayo,et al.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. , 2016, The New England journal of medicine.

[42]  N. Ford,et al.  Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for Achieving the UNAIDS 90-90-90 Targets , 2016, Current HIV/AIDS Reports.

[43]  R. Grant,et al.  Effectiveness and safety of oral HIV preexposure prophylaxis for all populations , 2016, AIDS.

[44]  J. D. de Wit,et al.  Awareness and knowledge of HIV pre-exposure prophylaxis among Australian gay and bisexual men: results of a national, online survey. , 2016, Sexual health.

[45]  S. Delany-Moretlwe,et al.  Promise and pitfalls of pre-exposure prophylaxis for female sex workers , 2016, Current opinion in HIV and AIDS.

[46]  D. Burns,et al.  Role of Oral Pre-exposure Prophylaxis (PrEP) in Current and Future HIV Prevention Strategies , 2014, Current HIV/AIDS Reports.

[47]  S. Buchbinder,et al.  Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco , 2014, PLoS medicine.

[48]  S. Philip,et al.  Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis. , 2013, American journal of preventive medicine.